Pigment Epithelium-derived Factor (PEDF) Shares Binding Sites in Collagen with Heparin/Heparan Sulfate Proteoglycans*

Pigment epithelium-derived factor (PEDF) is a collagen-binding protein that is abundantly distributed in various tissues, including the eye. It exhibits various biological functions, such as anti-angiogenic, neurotrophic, and neuroprotective activities. PEDF also interacts with extracellular matrix components such as collagen, heparan sulfate proteoglycans (HSPGs), and hyaluronan. The collagen-binding property has been elucidated to be important for the anti-angiogenic activity in vivo (Hosomichi, J., Yasui, N., Koide, T., Soma, K., and Morita, I. (2005) Biochem. Biophys. Res. Commun. 335, 756–761). Here, we investigated the collagen recognition mechanism by PEDF. We first narrowed down candidate PEDF-binding sequences by taking advantage of previously reported structural requirements in collagen. Subsequent searches for PEDF-binding sequences employing synthetic collagen-like peptides resulted in the identification of one of the critical binding sites for PEDF, human α1(I)(929–938) (IKGHRGFSGL). Further analysis revealed that the collagen recognition by PEDF is sequence- and conformation-specific, and the high affinity binding motif is KGXRGFXGL in the triple helix. The PEDF-binding motif significantly overlapped with the heparin/HSPG-binding motif, KGHRG(F/Y). The interaction of PEDF with collagen I was specifically competed with by heparin but not by chondroitin sulfate-C or hyaluronan. The binding sequences for PEDF and heparin/HSPG also overlapped with the covalent cross-linking sites between collagen molecules. These findings imply a functional relationship between PEDF and HSPGs during angiogenesis, and the interaction of these molecules is regulated by collagen modifications.

[1]  R. Seger,et al.  Pigment Epithelium-derived Factor and Its Phosphomimetic Mutant Induce JNK-dependent Apoptosis and p38-mediated Migration Arrest* , 2010, The Journal of Biological Chemistry.

[2]  R. Kramer,et al.  Sdc1 negatively modulates carcinoma cell motility and invasion. , 2010, Experimental cell research.

[3]  C. Min,et al.  Syndecan-1 Overexpression Promotes Tumor Growth and Angiogenesis in an Endometrial Cancer Xenograft Model , 2010, International Journal of Gynecologic Cancer.

[4]  T. Koide,et al.  Development of a high-throughput screening system for the compounds that inhibit collagen-protein interactions. , 2009, Analytical biochemistry.

[5]  Tahar Bouceba,et al.  Laminin Receptor Involvement in the Anti-angiogenic Activity of Pigment Epithelium-derived Factor*♦ , 2009, Journal of Biological Chemistry.

[6]  R. Kennedy,et al.  Characterization of PEDF: A multi‐functional serpin family protein , 2009, Journal of cellular biochemistry.

[7]  Neha S. Gandhi,et al.  The Structure of Glycosaminoglycans and their Interactions with Proteins , 2008, Chemical biology & drug design.

[8]  V. Notario,et al.  Pigment Epithelium-derived Factor Binds to Hyaluronan , 2008, Journal of Biological Chemistry.

[9]  S. Robins Biochemistry and functional significance of collagen cross-linking. , 2007, Biochemical Society transactions.

[10]  J. Enghild,et al.  Heparin Binding Induces a Conformational Change in Pigment Epithelium-derived Factor* , 2007, Journal of Biological Chemistry.

[11]  Raul Heredia,et al.  Identification of a Lipase-linked Cell Membrane Receptor for Pigment Epithelium-derived Factor* , 2006, Journal of Biological Chemistry.

[12]  W. Jiang,et al.  Pigment Epithelium-derived Factor Inhibits Angiogenesis via Regulated Intracellular Proteolysis of Vascular Endothelial Growth Factor Receptor 1* , 2006, Journal of Biological Chemistry.

[13]  I. Morita,et al.  Involvement of the collagen I-binding motif in the anti-angiogenic activity of pigment epithelium-derived factor. , 2005, Biochemical and biophysical research communications.

[14]  Y. Maehara,et al.  Cytoplasmic Expression and Extracellular Deposition of an Antiangiogenic Factor, Pigment Epithelium-Derived Factor, in Human Atherosclerotic Plaques , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[15]  J. Ramshaw,et al.  Prediction of Collagen Stability from Amino Acid Sequence* , 2005, Journal of Biological Chemistry.

[16]  M. Farach-Carson,et al.  Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds. , 2005, Tissue engineering.

[17]  H. Lankinen,et al.  Characterization of Collagenous Peptides Bound to Lysyl Hydroxylase Isoforms* , 2004, Journal of Biological Chemistry.

[18]  R. Linhardt,et al.  Heparin-Binding Domains in Vascular Biology , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Marta García,et al.  Inhibition of Xenografted Human Melanoma Growth and Prevention of Metastasis Development by Dual Antiangiogenic/Antitumor Activities of Pigment Epithelium-Derived Factor , 2004, Cancer Research.

[20]  K. Eguchi,et al.  Antiangiogenic property of pigment epithelium‐derived factor in hepatocellular carcinoma , 2004, Hepatology.

[21]  H. Shimizu,et al.  Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. , 2004, The American journal of pathology.

[22]  L. Montuenga,et al.  Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: apical secretion and distribution. , 2004, Experimental eye research.

[23]  T. Koide,et al.  Synthesis of heterotrimeric collagen models containing Arg residues in Y-positions and analysis of their conformational stability. , 2004, Bioorganic & medicinal chemistry letters.

[24]  N. Yasui,et al.  Collagen-protein interactions mapped by phototriggered thiol introduction. , 2003, Journal of the American Chemical Society.

[25]  J. Enghild,et al.  Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization. , 2003, The Biochemical journal.

[26]  J. Prieto,et al.  Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  U. Desai,et al.  Antithrombin III Phenylalanines 122 and 121 Contribute to Its High Affinity for Heparin and Its Conformational Activation* , 2003, The Journal of Biological Chemistry.

[28]  H. Kourai,et al.  Dual-site recognition of different extracellular matrix components by anti-angiogenic/neurotrophic serpin, PEDF. , 2003, Biochemistry.

[29]  E. Alberdi,et al.  Glycosaminoglycans in human retinoblastoma cells: Heparan sulfate, a modulator of the pigment epithelium-derived factor-receptor interactions , 2003, BMC Biochemistry.

[30]  Christina Meyer,et al.  Mapping the Type I Collagen-binding Site on Pigment Epithelium-derived Factor , 2002, The Journal of Biological Chemistry.

[31]  P. Gettins,et al.  Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Whisstock,et al.  The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins , 2001, The Journal of Biological Chemistry.

[33]  David F. Burke,et al.  Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.

[34]  J. Schlessinger,et al.  Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.

[35]  R. Farndale,et al.  The Collagen-binding A-domains of Integrins α1β1 and α2β1Recognize the Same Specific Amino Acid Sequence, GFOGER, in Native (Triple-helical) Collagens* , 2000, The Journal of Biological Chemistry.

[36]  W. Benedict,et al.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.

[37]  E. Alberdi,et al.  Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site. , 1998, Biochemistry.

[38]  Shawn M. Sweeney,et al.  Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Saga,et al.  Isolation, Purification, and Characterization of a Collagen-associated Serpin, Caspin, Produced by Murine Colon Adenocarcinoma Cells* , 1998, The Journal of Biological Chemistry.

[40]  D. Eyre,et al.  Molecular Site Specificity of Pyridinoline and Pyrrole Cross-links in Type I Collagen of Human Bone* , 1996, The Journal of Biological Chemistry.

[41]  S. P. Becerra,et al.  Proteolytic activity directed toward pigment epithelium-derived factor in vitreous of bovine eyes. Implications of proteolytic processing. , 1996, Investigative ophthalmology & visual science.

[42]  J. Ramshaw,et al.  A host-guest set of triple-helical peptides: stability of Gly-X-Y triplets containing common nonpolar residues. , 1996, Biochemistry.

[43]  T. Taniwaki,et al.  Pigment Epithelium‐Derived Factor Is a Survival Factor for Cerebellar Granule Cells in Culture , 1995, Journal of neurochemistry.

[44]  A. Lander,et al.  Interactions of syndecan-1 and heparin with human collagens. , 1994, Glycobiology.

[45]  R. Pignolo,et al.  Differential gene expression between young and senescent, quiescent WI-38 cells , 1992, Mechanisms of Ageing and Development.

[46]  M. Bernfield,et al.  Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens. , 1985, The Journal of biological chemistry.

[47]  D. Eyre,et al.  Identification of hydroxypyridinium cross-linking sites in type II collagen of bovine articular cartilage. , 1984, Biochemistry.

[48]  E. Wachter,et al.  Ordering of cyanogen bromide peptides of type III collagen based on their homology to type I collagen: preservation of sites for crosslink formation during evolution. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[49]  K. Kühn,et al.  The primary structure of collagen. , 1976, International review of connective tissue research.